Oncology Archives - Page 4 of 38 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Oncology

Study suggests MS patients are at a greater risk of cancer

Study suggests MS patients are at a greater risk of cancer

New genetic test helps predict side effects of chemotherapy

New genetic test helps predict side effects of chemotherapy

Antioxidants implicated in new understanding of how lung cancer spreads

Antioxidants implicated in new understanding of how lung cancer spreads

One in five haematological cancer patients suffer blood clots or bleeding

One in five haematological cancer patients suffer blood clots or bleeding

Lynparza approved for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer

Lynparza approved for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer

Pixuvri approved for use in Europe

Pixuvri approved for use in Europe

No link between cancer and TNF inhibitor use in psoriatic arthritis

No link between cancer and TNF inhibitor use in psoriatic arthritis

Pharmacies make a lifestyle impact for patients with prostate cancer

Pharmacies make a lifestyle impact for patients with prostate cancer

Scotland sees advance in treatment of kidney cancer

Scotland sees advance in treatment of kidney cancer

Protons to play a vital role in the battle against prostate cancer

Protons to play a vital role in the battle against prostate cancer

Long-term data from pivotal Phase III studies of ibrutinib presented at ASCO and EHA

Long-term data from pivotal Phase III studies of ibrutinib presented at ASCO and EHA

Stem cell differences could explain why women are more likely to develop adrenal cancer

Stem cell differences could explain why women are more likely to develop adrenal cancer

Using 3D to test personalised cancer treatments in five days

Using 3D to test personalised cancer treatments in five days

New strategy of reprogramming regulatory T cells may improve cancer therapies

New strategy of reprogramming regulatory T cells may improve cancer therapies

Liquid biopsy could identify cancer patients at risk of metastatic disease

Liquid biopsy could identify cancer patients at risk of metastatic disease